Form D Explorer

Form D — Avenzo Therapeutics, Inc.

0001231919-25-000185 · filed Sep 5, 2025

Offering

Industry
Biotechnology
Exemptions
06b
Total offering
$75,000,000
Total sold
$47,230,787
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Avenzo Therapeutics, Inc.
CIK
1947742
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2022
Address
12707 High Bluff Drive, Suite 200
SAN DIEGO, CA 92130
Phone
(858) 239-2944

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗